New York State, City sue Merck over Vioxx

Share this article:

New York State Attorney General Andrew Cuomo and New York City Mayor Michael Bloomberg have filed a joint lawsuit against Merck, alleging the drugmaker misrepresented the cardiovascular risks associated with its Vioxx painkiller.

The civil lawsuit, filed in New York State Supreme Court, seeks damages, penalties and restitution for taxpayer dollars wrongfully spent on Vioxx prescriptions. It is first case to be brought under New York State's recently enacted False Claims Act.

According to the New York Attorney General's Office, between 1999, when Vioxx was introduced, and 2004 when it was pulled from the market, Medicaid and EPIC spent over $100 million on Vioxx prescriptions in New York State. For its residents receiving Medicaid assistance, New York City paid a substantial share of those costs.

Merck said in a statement that it has not yet received the complaint filed by New York State and New York City seeking Medicaid reimbursement costs.

Merck said it intends to defend against the suit as it has defended against the Medicaid-related suits filed more than a year ago by a handful of other states including Alaska, Louisiana, Mississippi, Montana, Texas and Utah.

Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.